Patty Murray bought GlaxoSmithKline PLC ADR (NYSE: GSK)
Patty Murray (D-WA), a U.S. Senator, has disclosed 2 trades in GlaxoSmithKline PLC ADR (GSK) since 2017, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Patty Murray bought $1,001 - $15,000 of GlaxoSmithKline PLC ADR (NYSE: GSK) on March 16, 2017. Since that trade, GSK is up +89.26% against the S&P 500 up +260.23%, an outperformance of -170.97%.
Across these filings, Patty Murray has been a balanced trader of GSK (a buy-to-sell ratio of 1.00). The most recent disclosed GSK transaction shown was dated June 15, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Patty Murray's GSK trades vs the price
GSK is up +89.26% since Patty Murray bought on March 16, 2017, versus +260.23% for the S&P 500.
Performance since this trade
All Patty Murray GSK trades
Patty Murray & GSK trading FAQ
Is it legal for Patty Murray to trade GlaxoSmithKline PLC ADR (GSK) stock?
Yes. Members of Congress are allowed to trade individual stocks, including GlaxoSmithKline PLC ADR (GSK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Patty Murray buy GSK?
Patty Murray disclosed a purchase of $1,001 - $15,000 of GlaxoSmithKline PLC ADR (GSK) on March 16, 2017, according to public STOCK Act filings.
How has GSK performed since Patty Murray's trade?
Since Patty Murray bought GSK on March 16, 2017, the stock is up +89.26%, versus +260.23% for the S&P 500 over the same period, an outperformance of -170.97%.
How many times has Patty Murray traded GSK?
Patty Murray has disclosed 2 GSK trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GSK trades?
Quantellect tracks every disclosed congressional trade in GlaxoSmithKline PLC ADR (GSK) on the GlaxoSmithKline PLC ADR congressional trading page, which aggregates filings across all members of Congress.
Patty Murray's GSK tradesAll congressional filings for GlaxoSmithKline PLC ADRPatty Murray's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.